By Alicia Gallegos, amednews staff Physicians’ prescribing data can continue to be sold for marketing purposes, the Supreme Court rules. Manufacturers of generic drugs are not responsible for brand-name labeling errors. Brand-name and generic drug manufacturers have prevailed in two U.S. Supreme Court cases that could have wide-reaching effects on physicians who prescribe drugs and […]
3 Harvard Psychiatrists Disciplined Over Drug Company Ties
By Kristina C. Three Harvard psychiatrists, including a leading proponent in the off-label use of antipsychotics for bipolar disorder in children, have been disciplined by Harvard Medical School and Massachusetts General Hospital for not fully disclosing the extent of their ties to drug companies under the federal Physicians Payment Sunshine Act of 2010. Drs. Joseph […]
The great billion dollar drug scam: part two
By Khadija Sharife This is the second of a two-part series examining the methods by which multinational drug corporations inflate their expenses and justify their pricing strategies. The first part revealed how, far from costing the reported (and widely accepted) $1bn to bring a drug to market, actual costs may be less than a fifth […]
With World Support, an Ambitious Plan Would Vaccinate 90 Percent of Infants
By Donald G. McNeil, Jr. Haiti, which did a poor job of vaccinating its children even before the 2010 earthquake, has come up with a plan to immunize 90 percent of its newborns by 2015, the Pan American Health Organization announced last week. The country now needs over $100 million to carry it out. Assuming […]
Infectious Illnesses in Today’s America: How Concerned Should We Be?
By Robert Schecter Every night, those of us who have a TV are bombarded by a string of pharmaceutical company ads each one more ridiculous than the other. The one saving grace is that at the end of each, we’re at least encouraged to see our doctor to find out if this particular drug de […]
- « Previous Page
- 1
- …
- 20
- 21
- 22
- 23
- 24
- …
- 57
- Next Page »
